Therapeutic vs Prophylactic Anticoagulation for Severe COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Thrombosis Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Therapeutic Versus Prophylactic Anticoagulation for Severe COVID-19: A Randomized Phase II Clinical Trial (HESACOVID)
Thromb. Res. 2020 Sep 21;196(xx)359-366, ACB Lemos, DA do Espírito Santo, MC Salvetti, RN Gilio, LB Agra, A Pazin-Filho, CH MirandaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.